Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
3.325
-0.025 (-0.75%)
Nov 17, 2026, 11:29 AM AEDT

Australian Clinical Labs Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
615416540503694922
Market Cap Growth
17.42%-23.08%7.36%-27.51%-24.69%34.33%
Enterprise Value
9277088348051,0011,160
Last Close Price
3.352.172.562.222.943.51

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
26.9717.5316.6621.0319.345.17
Forward PE
17.4112.6613.9413.8315.929.64
PS Ratio
0.840.560.730.721.000.93
PB Ratio
4.152.783.142.834.023.96
P/TBV Ratio
--87.9239.9995.8213.75
P/FCF Ratio
4.032.703.103.295.083.51
P/OCF Ratio
3.802.552.963.154.833.25
PEG Ratio
2.582.560.743.000.780.78

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
1.270.961.131.161.441.17
EV/EBITDA Ratio
4.558.6510.2610.5512.564.05
EV/EBIT Ratio
13.4010.1812.2712.8715.354.24
EV/FCF Ratio
6.064.614.795.267.324.42

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
2.252.251.691.741.831.13
Debt / EBITDA Ratio
1.651.651.421.621.680.69
Debt / FCF Ratio
2.192.191.672.022.311.00
Net Debt / Equity Ratio
2.082.081.561.591.711.01
Net Debt / EBITDA Ratio
3.813.813.303.703.710.82
Net Debt / FCF Ratio
2.032.031.541.842.160.89
Asset Turnover
1.261.261.271.191.161.79
Inventory Turnover
30.4930.4928.3727.7225.3232.71
Quick Ratio
0.440.440.440.520.510.53
Current Ratio
0.540.540.560.640.620.64
Return on Equity (ROE)
14.93%14.93%18.77%13.84%17.79%113.46%
Return on Assets (ROA)
7.45%7.45%7.28%6.67%6.75%30.79%
Return on Invested Capital (ROIC)
9.68%9.91%10.29%8.98%10.40%46.95%
Return on Capital Employed (ROCE)
18.20%18.20%19.00%16.20%16.70%68.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
3.71%5.71%6.00%4.76%5.17%19.34%
FCF Yield
24.80%36.99%32.28%30.42%19.70%28.51%
Dividend Yield
3.91%5.79%4.50%4.78%4.04%11.54%
Payout Ratio
103.72%103.72%76.92%83.35%269.85%13.59%
Buyback Yield / Dilution
3.87%3.87%-0.30%0.82%0.18%-32.47%
Total Shareholder Return
7.75%9.65%4.20%5.59%4.23%-20.92%